CYPHERPUNK TECHNOLOGIES INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 19.81 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 19.81M shares, a 138.15% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 98.35M shares, a 928.20% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 6.59M shares, a 23.95% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 8.32M shares, a 3.69% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 20.42M shares, a 104.74% increase from fiscal 2024.
- CYPHERPUNK TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 9.97M shares, a 37.88% increase from fiscal 2023.
- CYPHERPUNK TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.23M shares, a 41.94% increase from fiscal 2022.
- CYPHERPUNK TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.10M shares, a 88.65% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 19.81M shares 10-Q · filed 2026-08-12 | 98.24M shares 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | 98.35M shares 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | 20.42M shares 10-K · filed 2026-03-16 | |||||||
| 2025-09-30 | 6.59M shares 10-Q · filed 2025-11-12 | 6.59M shares 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | 8.32M shares 10-Q · filed 2026-08-12 | 8.32M shares 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | 9.56M shares 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | 9.97M shares 10-K · filed 2026-03-16 | |||||||
| 2024-09-30 | 8.66M shares 10-Q · filed 2025-11-12 | 8.66M shares 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | 8.64M shares 10-Q · filed 2025-08-14 | 8.64M shares 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | 8.68M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 7.23M shares 10-K · filed 2025-03-26 | |||||||
| 2023-09-30 | 7.30M shares 10-Q · filed 2024-11-13 | 7.30M shares 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | 5.88M shares 10-Q · filed 2024-08-12 | 5.88M shares 10-Q · filed 2024-08-12 | ||||||
| 2023-03-31 | 4.74M shares 10-Q · filed 2024-05-13 | 58.43M shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 5.10M shares 10-K · filed 2024-03-18 | 50.96M shares 10-K · filed 2023-03-24 | ||||||
| 2022-09-30 | 5.10M shares 10-Q · filed 2023-11-13 | 50.97M shares 10-Q · filed 2022-11-14 | 5.10M shares 10-Q · filed 2023-11-13 | 50.97M shares 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 4.80M shares 10-Q · filed 2023-08-14 | 48.01M shares 10-Q · filed 2022-08-12 | 4.80M shares 10-Q · filed 2023-08-14 | 48.01M shares 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | 48.07M shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 44.92M shares 10-K · filed 2023-03-24 | |||||||
| 2021-09-30 | 45.35M shares 10-Q · filed 2022-11-14 | 45.35M shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 45.30M shares 10-Q · filed 2022-08-12 | 45.30M shares 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | 44.66M shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 43.13M shares 10-K · filed 2022-03-11 | |||||||
| 2020-09-30 | 43.07M shares 10-Q · filed 2021-11-12 | 43.07M shares 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | 42.18M shares 10-Q · filed 2021-08-13 | 42.18M shares 10-Q · filed 2021-08-13 | ||||||
| 2020-03-31 | 42.00M shares 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | 14.48M shares 10-K · filed 2021-03-12 | 14.39M shares 10-K · filed 2020-03-16 | ||||||
| 2019-09-30 | 14.39M shares 10-Q · filed 2020-11-12 | 14.39M shares 10-Q · filed 2020-11-12 | ||||||
| 2019-06-30 | 14.43M shares 10-Q · filed 2020-08-13 | 14.43M shares 10-Q · filed 2020-08-13 | ||||||
| 2019-03-31 | 13.28M shares 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | 2.82M shares 10-K · filed 2020-03-16 | |||||||
| 2018-09-30 | 2.69M shares 10-Q · filed 2019-11-14 | 5.44M shares 10-Q · filed 2019-11-14 | ||||||
| 2018-06-30 | 5.46M shares 10-Q · filed 2019-08-09 | 5.46M shares 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | 5.26M shares 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | 2.31M shares 10-K · filed 2019-04-01 | |||||||
| 2017-09-30 | 1.92M shares 10-Q · filed 2018-11-09 | 1.92M shares 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | 1.92M shares 10-Q · filed 2018-08-08 | 1.92M shares 10-Q · filed 2018-08-08 | ||||||
| 2017-03-31 | 1.92M shares 10-Q/A · filed 2018-08-08 | |||||||
| 2016-12-31 | 3.33M shares 10-K · filed 2018-02-23 | |||||||
| 2016-09-30 | 3.54M shares 10-Q · filed 2017-11-13 | 3.54M shares 10-Q · filed 2017-11-13 | ||||||
| 2016-06-30 | 3.49M shares 10-Q · filed 2017-08-11 | 3.49M shares 10-Q · filed 2017-08-11 | ||||||
| 2016-03-31 | 3.43M shares 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |